METTL3 and early-onset autosomal dominant Alzheimer disease: (2020) confirmed aberrant METTL3 levels in the hippocampus of the Alzheimer's disease patients brain induced an epitranscriptomic mechanism, which resulted in the changes in related gene expression patterns in Alzheimer's disease.